Rolling Submission of NDA for Aficamten Completed and Submitted to FDA in Q3COMET-HF, Confirmatory Phase 3 Clinical Trial of Omecamtiv ...

Positive results from completed Phase 2 study of mavorixafor in chronic neutropenia (CN) announced todayPivotal Phase 3 trial of mavorixafor in ...

Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...

The global periodontal disease treatment market is projected to reach USD 3.63 billion by 2030 from USD 2.58 billion in 2024, ...

The agency said an extensive review of available ... Last year, CVS said it has already moved to pull certain medicines containing oral phenylephrine. A final order would also require drugmakers ...

Aptamer Group plc (AIM: APTA), the developer of novel Optimer ® binders to enable innovation in the life sciences industry, is pleased to announce that a genetic medicines customer has selected ...

As the US presidential election result became clear, European leaders followed a similar formula when congratulating President-elect Trump. They offered their congratulations, mentioned previous good ...

US President-elect Donald Trump, who has repeatedly boasted that he could end the Russia-Ukraine war in his first 24 hours in power, is likely to call on European soldiers to enforce an 800-mile ...

In the past decade, CPP has achieved significant success, including seven regulatory milestones, including the first ...

I was born in the United States but travel widely and often think about moving abroad. I also want my children to have the option if they ever want to leave the US. In more recent years, as I ...